BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14441885)

  • 1. [Poisoning by the ergot of rye. (One of its alkaloids: ergonovine)].
    SASTRE MACEDO M; ORTEGA CL; HEPNER M
    Dia Med; 1960 May; 32():861. PubMed ID: 14441885
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent chemical research on the alkaloids of ergot of rye].
    STOLL A
    Farmaco Sci Tec; 1951; 6(4):475-94. PubMed ID: 14872881
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the content of alkaloids in domestic wild rye ergot].
    TROPP MIa; SINILOVA NG
    Med Prom SSSR; 1961 Aug; 8():10-4. PubMed ID: 14039807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some recent developments on the pharmacology of ergot of rye].
    ROTHLIN E; FANCHAMPS A
    Rev Pathol Gen Physiol Clin; 1955 Dec; 55(673):1427-43. PubMed ID: 13298391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ergot cultivation on tetraploid rye].
    DEUFEL J
    Arch Pharm Ber Dtsch Pharm Ges; 1954; 287(6):329-32. PubMed ID: 13198207
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypothermic neuroplegia, called artificial hibernation, with dihydrogenated derivatives of ergot of rye; physiological study].
    CAHN J; MELON JM; DUBRASQUET ; BODIOU
    Anesth Anal; 1954 Oct; 11(3):513-32. PubMed ID: 15444698
    [No Abstract]   [Full Text] [Related]  

  • 7. [PRIMARY DYSMENORRHEA. TRIAL TREATMENT WITH A DERIVATIVE OF RYE ERGOT].
    CHABRIER J; BARRIER J
    Rev Fr Gynecol Obstet; 1964; 59():345-53. PubMed ID: 14169676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical studies of the dihydrogenated alkaloids of ergot of rye].
    SCHNEIDER PB
    Schweiz Arch Neurol Psychiatr; 1950; 65(1-2):283-310. PubMed ID: 15430992
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of tail gangrene in thyroxin-treated rats following administration of natural and hydrogenated alkaloids of ergot.
    MASSOPUST LC; SOMMER AF; WILLSON JT; BUCHANAN AR
    J Int Coll Surg; 1953 May; 19(5):592-8. PubMed ID: 13044977
    [No Abstract]   [Full Text] [Related]  

  • 10. Artificial inoculation of rye with ergot; a susceptible rye and the control of ergot beetles.
    LEWIS RW
    J Am Pharm Assoc Am Pharm Assoc; 1948 Dec; 37(12):511-3. PubMed ID: 18122597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of maniacal syndromes by dihydrogenated alkaloids of ergot of rye (hydergine) associated with electroshock].
    POSTEL J; COSSA P; BERNUY M
    Ann Med Psychol (Paris); 1956 Jun; 114(1):75-80. PubMed ID: 13340372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of peripheral circulatory disorders with hydrogenated alkaloids of ergot of rye].
    ZOZAYA RG
    Presse Med (1893); 1956 Jun; 64(47):1086-7. PubMed ID: 13350074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical study on the association of a fraction of Veratrum viride with a derivative of ergot of rye].
    AGUAYO A; GRANIER M; HORANDE M
    Gac Med Caracas; 1956; 64(1-2):81-6. PubMed ID: 13365825
    [No Abstract]   [Full Text] [Related]  

  • 14. [The occurrence of ergotamine in Spanish ergot of rye].
    POHM M
    Experientia; 1954 Nov; 10(11):460. PubMed ID: 14353062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Particular association of spurred rye alkaloids in obstetrics].
    PESCETTO G
    Riv Ostet Ginecol Prat; 1949 Dec; 31(12):543-6. PubMed ID: 15404061
    [No Abstract]   [Full Text] [Related]  

  • 16. Superficial gangrene of extremities due to ergot poisoning.
    LOE RH
    Northwest Med; 1948 Mar; 47(3):190-2. PubMed ID: 18906883
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE BIOSYNTHESIS OF PEPTIDE ALKALOIDS FROM CLAVICEPS PURPUREA TUL].
    VOIGT R; BORNSCHEIN M
    Pharmazie; 1964 Dec; 19():772-5. PubMed ID: 14339166
    [No Abstract]   [Full Text] [Related]  

  • 18. The hydrogenated alkaloids of ergot in geriatrics.
    POPKIN RJ
    Am Pract Dig Treat; 1952 Jul; 3(7):532-5. PubMed ID: 12986116
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible dangers from blind acceptance of an established routine; untoward reactions to ergot.
    SHULMAN LJ
    West J Surg Obstet Gynecol; 1961; 69():384-7. PubMed ID: 13912391
    [No Abstract]   [Full Text] [Related]  

  • 20. The obstetrical use of ergot: a violation of the doctrine "primum non nocere".
    RINGROSE CA
    Can Med Assoc J; 1962 Sep; 87(13):712-4. PubMed ID: 14492373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.